Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
Antonis C. Antoniou(Weatherford College), Douglas F. Easton(University of Cambridge), Deborah J. Thompson, Julian Peto(London School of Hygiene & Tropical Medicine), Jan Lubiński(Tumour Institute of Tuscany), Barbara Pasini(University of Turin), Siranoush Manoukian(Fondazione IRCCS Istituto Nazionale dei Tumori), Oskar T. Johannsson(Lapland Central Hospital), Bohdan Górski(International Hereditary Cancer Center), Olli Kallioniemi(University of Helsinki), Heli Nevanlinna(University of Helsinki), Ellen Warner(Sylvester Comprehensive Cancer Center), Hrafn Tulinius(University of Iceland), Kirsi Syrjäkoski(Tampere University Hospital), Hannaleena Eerola(Helsinki University Hospital), Hoda Anton‐Culver(University of California, Irvine), Steinunn Thorlacius(deCODE Genetics (Iceland)), Chris Evans(Adaptimmune (United Kingdom)), D. Gareth Evans(Manchester Academic Health Science Centre), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Steven A. Narod(Women's College Hospital), Jacek Gronwald(International Hereditary Cancer Center), Nelson L.S. Tang(Chinese University of Hong Kong), Paolo Radice(IFOM), J.E. Eyfjörd(Reykjavík University), John L. Hopper(The University of Melbourne), Åke Borg(Lund University), Niklas Loman(Lund University), Edith Oláh(National Institute of Oncology), Fiona Lalloo(Manchester Academic Health Science Centre), Håkan Olsson(Nokia (Finland)), Diana Eccles(Princess Anne Hospital), Harvey A. Risch(University of New Haven)
Cited by 3,697
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k